GoodRx Holdings, Inc. Reports Q2 2026 Financial Results

What Happened

• On August 5, 2026, GoodRx Holdings, Inc. announced its financial results for the three and six months ended June 30, 2026 via a press release furnished with an 8-K (Item 2.02). The full press release is included as Exhibit 99.1 to the filing.

Key Details

• Filing date: August 5, 2026.
• Reporting period: three and six months ended June 30, 2026 (Q2 2026).
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• The cover page Interactive XBRL data is embedded in the Inline XBRL document; the Form 8-K is signed by Christopher McGinnis, Chief Financial Officer & Treasurer.

Why It Matters

• This 8-K signals GoodRx has released its Q2 2026 quarterly results; those results (revenue, earnings, margins, guidance) are contained in the press release and are material to investors assessing the company’s recent performance and trends.
• Investors should review the Exhibit 99.1 press release and any accompanying investor materials or SEC filings for the specific financial figures and management commentary to evaluate impacts on revenue growth, profitability, and outlook.